Back to AXIOM INVESTORS LLC /DE AXIOM INVESTORS LLC /DE

PTGXPTGX
6 quarters

Position history for AXIOM INVESTORS LLC /DEAXIOM INVESTORS LLC /DE's holdings in PROTAGONIST THERAPEUTICS INC

AXIOM INVESTORS LLC /DE holds 81,683 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $10M as of 2026-Q2. The position was decreased (-4.4% shares). PTGX represents 0.1% of AXIOM INVESTORS LLC /DE's portfolio.

Current Value

$10M

Current Shares

81,683

Total Value Change

+$6.1M

Total Shares Change

+1,745

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
81,683
-4.4%
$10M0.1%$122.58
0
2026-Q1
Decreased
85,475
-4.5%
$9M0.1%$91.30
0
2025-Q4
Increased
89,468
+11.7%
$7.8M0.1%$87.26
31
2025-Q3
Increased
80,113
+56.4%
$5.3M0.0%$65.14
38
2025-Q2
Decreased
51,233
-35.9%
$2.8M0.0%$55.69
0
2025-Q1
New
79,938
-
$3.9M0.0%$48.88
37

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used